Status:
WITHDRAWN
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Lead Sponsor:
Santa Barbara Cottage Hospital
Conditions:
Alcohol Withdrawal Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of this study will aim to determine if adding phenobarbital or ketamine to a symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions during the treatment...
Detailed Description
The primary objective of this study is to compare phenobarbital and ketamine adjunctive therapies to lorazepam-based therapy in the treatment of acute alcohol withdrawal syndrome. It is hypothesized ...
Eligibility Criteria
Inclusion
- Primary admitting diagnosis of acute alcohol withdrawal syndrome based on International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), code F10.3, F10.4.
Exclusion
- Significant comorbid medical illness requiring Intensive Care Unit admission;
- Pregnancy;
- Inability to obtain intravenous access;
- Child Pugh Class C; and
- Allergy to study medications (phenobarbital, ketamine, lorazepam).
Key Trial Info
Start Date :
April 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03788889
Start Date
April 12 2019
End Date
April 12 2019
Last Update
September 19 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.